본문 바로가기
KERD
논문KCI 등재

뇌졸중에서 우울증과 실행기능부전에 대한 고찰

Depression and Executive Dysfunction in Stroke

이소영|정한용|김신겸|나경세
대한생물정신의학회 (The Korean Society Of Biological Psychiatry)|2012.11|생물정신의학 (Journal of Korean Society of Biological Psychiatry)|제19권 제4호|pp. 179-786

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

Depression우울증뇌졸중Stroke항우울제Antidepressant실행기능부전Executive dysfunction
주제분류정신과학

초록

Depression and executive dysfunction are common neuropsychiatric sequelae of stroke. Patients with stroke are more predisposed to depression and executive dysfunction compared to patients with similar degree of physical disability. Both depression and executive dysfunction are also associated with poor prognosis such as high mortality and delayed recovery after stroke. Complex neurobiological and anatomical mechanisms are associated with the development of depression and executive dysfunction after stroke. Activation of pro-inflammatory cytokines is thought to be associated with onset of depression, whereas injuries in frontal-subcortical circuit are thought to be a link between depression and executive dysfunction. Early detection of depressive symptoms and both pharmacological and non-pharmacological treatment would be helpful. In this review paper, the authors investigated 1) biological and neuroanatomical substrate for poststroke depression and executive dysfunction, 2) the relationship and common etiopathology for poststroke depression and executive dysfunction, and 3) pharmacological and non-pharmacological treatment for poststroke depression. The contents of the paper are as follows : the prevalence, clinical manifestation, and biological etiology for poststroke depression, neuroanatomical abnormalities as a common etiological factor for depression and executive dysfunction, pharmacotherapy and non-pharmacological approach.

Abstract

Depression and executive dysfunction are common neuropsychiatric sequelae of stroke. Patients with stroke are more predisposed to depression and executive dysfunction compared to patients with similar degree of physical disability. Both depression and executive dysfunction are also associated with poor prognosis such as high mortality and delayed recovery after stroke. Complex neurobiological and anatomical mechanisms are associated with the development of depression and executive dysfunction after stroke. Activation of pro-inflammatory cytokines is thought to be associated with onset of depression, whereas injuries in frontal-subcortical circuit are thought to be a link between depression and executive dysfunction. Early detection of depressive symptoms and both pharmacological and non-pharmacological treatment would be helpful. In this review paper, the authors investigated 1) biological and neuroanatomical substrate for poststroke depression and executive dysfunction, 2) the relationship and common etiopathology for poststroke depression and executive dysfunction, and 3) pharmacological and non-pharmacological treatment for poststroke depression. The contents of the paper are as follows : the prevalence, clinical manifestation, and biological etiology for poststroke depression, neuroanatomical abnormalities as a common etiological factor for depression and executive dysfunction, pharmacotherapy and non-pharmacological approach.

참고문헌 (67)

  1. Lenzi GL, "Post-stroke depression", Rev Neurol (Paris), 164, pp.837~840 (2008)
  2. Maes M, "The inflammatory & neurodegenerative (I & ND) hypothesis of depression: leads for future research and new drug developments in depression", Metab Brain Dis, 24, pp.27~53 (2009)
  3. Di Carlo A, "Frequency of stroke in Europe: A collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging", Neurology, 54(11 Suppl 5), pp.S28~S33 (2000)
  4. Maes M, "Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms", Curr Opin Psychiatry, 22, pp.75~83 (2009)
  5. Aben I, "A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction", J Neurol Neurosurg Psychiatry, 74, pp.581~585 (2003)
  6. Robinson RG, "Poststroke depression: prevalence, diagnosis, treatment, and disease progression", Biol Psychiatry, 54, pp.376~387 (2003)
  7. Folstein MF, "Mood disorder as a specific complication of stroke", J Neurol Neurosurg Psychiatry, 40, pp.1018~1020 (1977)
  8. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders. 4th ed" (1994), American Psychiatric Association
  9. Morris PL, "Association of depression with 10-year poststroke mortality", Am J Psychiatry, 150, pp.124~129 (1993)
  10. Wade DT, "Depressed mood after stroke. A community study of its frequency", Br J Psychiatry, 151, pp.200~205 (1987)
  11. Müller N, "COX-2 inhibition in schizophrenia and major depression", Curr Pharm Des, 14, pp.1452~1465 (2008)
  12. Elenkov IJ, "Cytokine dysregulation, inflammation and well-being", Neuroimmunomodulation, 12, pp.255~269 (2005)
  13. Loftis JM, "Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies", Neurobiol Dis, 37, pp.519~533 (2010)
  14. Connor TJ, "Depression, stress and immunological activation: the role of cytokines in depressive disorders", Life Sci, 62, pp.583~606 (1998)
  15. Nichols KK, "The international workshop on meibomian gland dysfunction: executive summary", Invest Ophthalmol Vis Sci, 52, pp.1922~1929 (2011)
  16. Gabbay V, "The possible role of the kynurenine pathway in adolescent depression with melancholic features", J Child Psychol Psychiatry, 51, pp.935~943 (2010)
  17. Miller AH, "Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression", Biol Psychiatry, 65, pp.732~741 (2009)
  18. 나경세, "Monocytic, Th1 and Th2 cytokine alterations in the pathophysiology of schizophrenia", NEUROPSYCHOBIOLOGY, 56(2-3), pp.55~63 (2007), KARGER
  19. Dobos N, "The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation- induced depression", J Alzheimers Dis, 28, pp.905~915 (2012)
  20. Lyons KE, "Monitoring, metacognition, and executive function: elucidating the role of self-reflection in the development of self-regulation", Adv Child Dev Behav, 40, pp.379~412 (2011)
  21. Broomfield NM, "Post-stroke depression: the case for augmented, individually tailored cognitive behavioural therapy", Clin Psychol Psychother, 18, pp.202~217 (2011)
  22. Royall DR, "Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association", J Neuropsychiatry Clin Neurosci, 14, pp.377~405 (2002)
  23. Duke LM, "Executive control functions in degenerative dementias: a comparative review", Neuropsychol Rev, 10, pp.75~99 (2000)
  24. Cummings JL, "Frontal-subcortical circuits and human behavior", Arch Neurol, 50, pp.873~880 (1993)
  25. Devinsky O, "Contributions of anterior cingulate cortex to behaviour", Brain, 118(Pt 1), pp.279~306 (1995)
  26. Walter M, "The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression", Arch Gen Psychiatry, 66, pp.478~486 (2009)
  27. Campbell JJ 3rd, "Neuropsychiatric significance of subcortical hyperintensity", J Neuropsychiatry Clin Neurosci, 13, pp.261~288 (2001)
  28. van Swieten JC, "Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces", Brain, 114(Pt 2), pp.761~774 (1991)
  29. Pantoni L, "Pathogenesis of leukoaraiosis: a review", Stroke, 28, pp.652~659 (1997)
  30. Jokinen H, "Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study", Cerebrovasc Dis, 27, pp.384~391 (2009)
  31. Radanovic M, "Contribution to the evaluation of language disturbances in subcortical lesions: a pilot study", Arq Neuropsiquiatr, 62, pp.51~57 (2004)
  32. Frisoni GB, "Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome", J Neurol, 249, pp.1423~1432 (2002)
  33. Kramer JH, "Executive dysfunction in subcortical ischaemic vascular disease", J Neurol Neurosurg Psychiatry, 72, pp.217~220 (2002)
  34. O’Sullivan M, "Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis", Neurology, 59, pp.321~326 (2002)
  35. Debette S, "The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis", BMJ, 341, pp.c3666~ (2010)
  36. Herrmann LL, "White matter hyperintensities in late life depression: a systematic review", J Neurol Neurosurg Psychiatry, 79, pp.619~624 (2008)
  37. Greenwald BS, "MRI signal hyperintensities in geriatric depression", Am J Psychiatry, 153, pp.1212~1215 (1996)
  38. de Groot JC, "Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study", Ann Neurol, 47, pp.145~151 (2000)
  39. Vataja R, "Magnetic resonance imaging correlates of depression after ischemic stroke", Archives of general psychiatry, 58, pp.925~931 (2001)
  40. Pariel-Madjlessi S, "Depression: an underrated consequence of stroke in elderly", Psychol Neuropsychiatr Vieil, 3, pp.7~16 (2005)
  41. Alexopoulos GS, "Clinical presentation of the “depression-executive dysfunction syndrome” of late life", Am J Geriatr Psychiatry, 10, pp.98~106 (2002)
  42. Alexopoulos GS, "‘Vascular depression’ hypothesis", Arch Gen Psychiatry, 54, pp.915~922 (1997)
  43. Alexopoulos GS, "Role of executive function in late-life depression", J Clin Psychiatry, 64(Suppl 14), pp.18~23 (2003)
  44. Lockwood KA, "Executive dysfunction in geriatric depression", Am J Psychiatry, 159, pp.1119~1126 (2002)
  45. Bour A, "Depressive symptoms and executive functioning in stroke patients: a follow-up study", Int J Geriatr Psychiatry, 26, pp.679~686 (2011)
  46. Cui X, "Does depression precede or follow executive dysfunction? Outcomes in older primary care patients", Am J Psychiatry, 164, pp.1221~1228 (2007)
  47. Melkas S, "Depression-executive dysfunction syndrome relates to poor poststroke survival", Am J Geriatr Psychiatry, 18, pp.1007~1016 (2010)
  48. Carson AJ, "Depression after stroke and lesion location: a systematic review", Lancet, 356, pp.122~126 (2000)
  49. Vataja R, "Magnetic resonance imaging correlates of depression after ischemic stroke", Arch Gen Psychiatry, 58, pp.925~931 (2001)
  50. Bolla-Wilson K, "Lateralization of dementia of depression in stroke patients", Am J Psychiatry, 146, pp.627~634 (1989)
  51. Spalletta G, "Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness", J Neurol, 249, pp.1541~1551 (2002)
  52. Robinson RG, "Poststroke depression: a review", Can J Psychiatry, 55, pp.341~349 (2010)
  53. Fruehwald S, "Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up", J Neurol, 250, pp.347~351 (2003)
  54. Rasmussen A, "A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients", Psychosomatics, 44, pp.216~221 (2003)
  55. Robinson RG, "Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial", JAMA, 299, pp.2391~2400 (2008)
  56. Jorge RE, "Escitalopram and enhancement of cognitive recovery following stroke", Arch Gen Psychiatry, 67, pp.187~196 (2010)
  57. Almeida OP, "Preventing depression after stroke: Results from a randomized placebo-controlled trial", J Clin Psychiatry, 67, pp.1104~1109 (2006)
  58. Palomäki H, "Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy", J Neurol Neurosurg Psychiatry, 66, pp.490~494 (1999)
  59. Bondareff W, "Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life", Am J Psychiatry, 157, pp.729~736 (2000)
  60. Grigsby J, "Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study", J Am Geriatr Soc, 46, pp.590~596 (1998)
  61. Lincoln NB, "Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study", Clin Rehabil, 11, pp.114~122 (1997)
  62. Lincoln NB, "Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial", Stroke, 34, pp.111~115 (2003)
  63. Rasquin SM, "Cognitive-behavioural intervention for depression after stroke: five single case studies on effects and feasibility", Neuropsychol Rehabil, 19, pp.208~222 (2009)
  64. Watkins CL, "Motivational interviewing early after acute stroke: a randomized, controlled trial", Stroke, 38, pp.1004~1009 (2007)
  65. Smith J, "Information provision for stroke patients and their caregivers", Cochrane Database Syst Rev, pp.CD001919~ (2008)
  66. Williams LS, "Care management of poststroke depression: a randomized, controlled trial", Stroke, 38, pp.998~1003 (2007)
  67. Mohlman J, "The role of executive functioning in CBT: a pilot study with anxious older adults", Behav Res Ther, 43, pp.447~465 (2005)

관련 논문AI추천

뇌졸중후우울증의 발병기전 : 생물-심리-사회적 통합 모형강희주, 김성완, 김재민, 신일선, 윤진상대한신경정신의학회 · 신경정신의학2011 · 제50권 제5호뇌졸중 후의 우울증 - 유병률과 경과 및 뇌손상 부위와의 관련성에 관한 문헌 개관 -한국심리학회 · 한국심리학회지:일반1996 · 제15권 제1호뇌졸중 환자에서 뇌졸중 후 우울증상의 중증도와 인지기능의 상관관계유승돈, 전민호, 편성범대한재활의학회 · Annals of Rehabilitation Medicine2009 · 제33권 제5호뇌졸중 후 우울증손민균대한뇌신경재활학회 · 뇌신경재활2015 · 제8권 제2호혈관성 우울증의 개념, 병인기전, 치료와 예후김병수대한생물치료정신의학회 · 생물치료정신의학2014 · 제20권 제1호Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on MechanismsJong S. Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2016 · 제18권 제3호

이 간행물의 다른 논문 (9건)

임상시험의 단계별 이해 및 실제최성구pp. 153-158정신과 연구에서 다양한 임상연구방법의 장단점하라연, 조현상pp. 159-163위약효과와 신경정신약물의 임상시험김성완, 장지은, 윤진상pp. 164-171임상연구의 설계 및 연구윤리윤인영, 이선이, 하태현, 장재승, 하규섭pp. 172-178항정신병약물 클로자핀이 흰쥐 뇌실로 주입한 인슐린의 반응에 미치는 영향김세현, 박홍근, 유현숙, 김용식, 박소영, 김민경pp. 187-192
원문 보기